Marta Casillas

5PUBLICATIONS
29CO-AUTHORS
Epidemiological methodsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Oct 18, 2024
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.

Jonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold

|Aug 09, 2024
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.

Jonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold

|Nov 08, 2023
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.

Gil Yosipovitch, Peter A Lio, David Rosmarin

|Apr 26, 2021
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies.

Timo Buhl, David Rosmarin, Esther Serra-Baldrich

Pageof 1

Frequent Collaborators

3 joint publications

Linda Stein Gold

3 joint publications

Gil Yosipovitch

3 joint publications

Peter Lio

3 joint publications

Evangeline Pierce